Abstract | OBJECTIVE: METHODS:
Formalin-fixed paraffin-embedded pretreatment tumor tissue from 233 patients with known HPV/ p16(INK4A) status was analyzed. CXCL12 and CXCR4 expressions were correlated with pretreatment parameters and survival data by univariate and multivariate Cox regression. RESULTS: CXCL12 was expressed in 43.3 % and CXCR4 in 66.1 % of the samples and both were correlated with HPV/ p16(INK4A) positivity. A high CXCL12 expression was associated with increased overall survival (p = 0.036), while a high CXCR4 expression was associated with decreased metastasis-free survival (p = 0.034). CONCLUSION:
|
Authors | Margret Rave-Fränk, Narges Tehrany, Julia Kitz, Martin Leu, Hanne Elisabeth Weber, Peter Burfeind, Henning Schliephake, Martin Canis, Tim Beissbarth, Holger Michael Reichardt, Hendrik Andreas Wolff |
Journal | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
(Strahlenther Onkol)
Vol. 192
Issue 1
Pg. 47-54
(Jan 2016)
ISSN: 1439-099X [Electronic] Germany |
PMID | 26374452
(Publication Type: Journal Article)
|
Chemical References |
- CXCL12 protein, human
- CXCR4 protein, human
- Chemokine CXCL12
- Cyclin-Dependent Kinase Inhibitor p16
- Receptors, CXCR4
|
Topics |
- Adult
- Aged
- Carcinoma, Squamous Cell
(genetics, mortality, pathology, therapy)
- Chemokine CXCL12
(genetics)
- Chemoradiotherapy
- Cohort Studies
- Cyclin-Dependent Kinase Inhibitor p16
(genetics)
- Disease Progression
- Female
- Follow-Up Studies
- Humans
- Lymphatic Metastasis
(pathology)
- Male
- Middle Aged
- Neoplasm Staging
- Otorhinolaryngologic Neoplasms
(genetics, mortality, pathology, therapy)
- Prognosis
- Receptors, CXCR4
(genetics)
- Statistics as Topic
- Survival Rate
|